Using a TNF inhibitor for late-onset AS as safe, effective as early onset
Tumor necrosis factor inhibitors (TNFi) appear to work as well and be as safe for adults with late-onset ankylosing spondylitis (AS) as they are for those with earlier symptoms, offering an additional treatment option for older patients, a real-world study suggests. The study, “Assessing safety and efficacy of…